Review: Hypertension, a health economics perspective

@article{Alcocer2008ReviewHA,
  title={Review: Hypertension, a health economics perspective},
  author={Luis Antonio Alcocer and Liliana Cueto},
  journal={Therapeutic Advances in Cardiovascular Disease},
  year={2008},
  volume={2},
  pages={147 - 155}
}
  • L. Alcocer, L. Cueto
  • Published 1 June 2008
  • Medicine, Economics
  • Therapeutic Advances in Cardiovascular Disease
The economic aspects of hypertension are critical to modern medicine. The medical, economic, and human costs of untreated and inadequately controlled hypertension are enormous. Hypertension is distributed unequally and with iniquity in different countries and regions of the world. Treatment of hypertension requires an investment over many years to prolong disease-free quality years of life. The high prevalence and high cost of the disease impacts on the microeconomics and macroeconomics of… 

Critical aspects in hypertension diagnosis and treatment

TLDR
Previously, the reliability of patient self-assessed blood pressures was questioned based on poor accuracy and reproducibility of the available automated blood pressure monitoring devices, but modern technology has largely solved such problems, as demonstrated by Germano and coworkers in their assessment of four automatic devices for selfmeasurement of blood pressure.

Hypertension management: an update.

TLDR
New guidelines for optimal evaluation of hypertension and current therapeutic options available to combat this common yet pervasive disease are reviewed.

Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019

TLDR
The results show that the main Brazilian strategy to combat SAH was implemented in primary care, namely access to free antihypertensive drugs and multiprofessional teams, acting jointly to promote care and prevent and control SAH.

Hypertension in the Elderly: A Perspective

TLDR
Management of HT in elderly patients is complex and challenging because of existent comorbidities and concerns related to drug dosages and resultant adverse effects, often leading to poor blood pressure control.

Hypertension treatment in a section of the prescribed management benefit market in South Africa

TLDR
This research was embedded in a drug utilisation review approach supported by various other measuring instruments, classification systems, arithmetical formulas and descriptive statistical methods and revealed that most observations were made for prescriptions consisting of two and three-item antihypertensive medications respectively.

Applicability of the current hypertension guidelines in Latin America

TLDR
Developing evidence-based guidelines is not enough to affect positively the burden of disease caused by hypertension, therefore, professional programs are required for the implementation of such guidelines as well as the auditing of their results.

Hypertension 3 Hypertension in developing countries

TLDR
Findings from serial surveys show an increasing prevalence of hypertension in developing countries, possibly caused by urbanisation, ageing of population, changes to dietary habits, and social stress.

Recommendations for the treatment of hypertension in the elderly and very elderly--a scotoma within international guidelines.

TLDR
This review article compares six international guidelines as well as the consensus document of the ACCF/AHA 2011 in terms of their recommendations of drug classes, target blood pressure values and the use of combination therapy.

Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension

TLDR
Significant efforts have been made in developing new classes of drugs that lower BP; with several of these emerging classes in phase III clinical trials, it is hoped that the discovery of these novel therapeutic avenues will aid in reducing the global burden of hypertension.

References

SHOWING 1-10 OF 30 REFERENCES

Introduction to health economics for the medical practitioner

  • D. Kernick
  • Medicine, Political Science
    Postgraduate medical journal
  • 2003
TLDR
Health economics seeks to facilitate decision making by offering an explicit decision making framework based on the principle of efficiency and economic evaluation is reviewed.

NIH promotes use of lower cost drugs for hypertension

  • D. Spurgeon
  • Medicine, Political Science
    BMJ : British Medical Journal
  • 2004
TLDR
The US National Institutes of Health is planning to use some 600 prominent doctors in the United States, Canada, and Puerto Rico to promote the use of lower cost drugs to treat hypertension.

Hypertension in developing economies: a review of population‐based studies carried out from 1980 to 1998

TLDR
Differences in methodology between national surveys make international comparisons difficult, Nevertheless, low-cost hypertension control programmes in developing countries are needed, along with development of the primary prevention of hypertension.

Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level

TLDR
Current guidelinesbased on blood pressure levels are both more expensive and less effective than guidelines based on absolute risk of cardiovascular disease in South Africa, which could free up major resources for other pressing needs, especially in developing countries.

Socioeconomic factors and cardiovascular disease: a review of the literature.

TLDR
There has been a consistent inverse relation between cardiovascular disease, primarily coronary heart disease, and many of the indicators of SES, and evidence for this relation has been derived from prevalence, prospective, and retrospective cohort studies.

Economic evaluation: an introduction

TLDR
This is the first in a series of occasional notes on economics that describes how economic evaluation is increasingly specified in research grants from both the NHS and pharmaceutical companies.

Costing interventions in primary care.

  • D. Kernick
  • Medicine, Political Science
    Family practice
  • 2000
TLDR
This paper outlines some costing concepts and principles to enable primary care practitioners and researchers to have a basic understanding of costing exercises and their pitfalls.